Lopinavir/ritonavir absorption in a gastrectomized patient

被引：13

作者：

Boffito, M ^{[1
]}

Lucchini, A

Maiello, A

Dal Conte, I

Hoggard, PG

Back, DJ

Di Perri, G

机构：

[1] Univ Turin, Dept Infect Dis, Turin, Italy

[2] Univ Liverpool, Dept Pharmacol, Liverpool L69 3BX, Merseyside, England

来源：

AIDS | 2003年 / 17卷 / 01期

关键词：

D O I：

10.1097/00002030-200301030-00023

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：136 / 137

页数：2

共 7 条

[1]

[Anonymous], 1992, MMWR-MORBID MORTAL W, V41, P1

[2] The role of therapeutic drug monitoring in treatment of HIV infection [J].

Back, DJ ;

Khoo, SH ;

Gibbons, SE ;

Merry, C .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (04) :301-308

[3] ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results [J].

Murphy, RL ;

Brun, S ;

Hicks, C ;

Eron, JT ;

Gulick, R ;

King, M ;

White, AC ;

Benson, C ;

Thompson, M ;

Kessler, HA ;

Hammer, S ;

Bertz, R ;

Hsu, A ;

Japour, A ;

Sun, E .

AIDS, 2001, 15 (01) :F1-F9

[4]

*PAN CLIN PRACT TR, 1998, ANN INTERN MED, V128, P1079

[5]

REYNOLDS HE, 2001, BR J CLIN PHARM, V52, pP481

[6]

SCHANKER LS, 1957, J PHARMACOL EXP THER, V120, P528

[7] ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease [J].

Sham, HL ;

Kempf, DJ ;

Molla, A ;

Marsh, KC ;

Kumar, GN ;

Chen, CM ;

Kati, W ;

Stewart, K ;

Lal, R ;

Hsu, A ;

Betebenner, D ;

Korneyeva, M ;

Vasavanonda, S ;

McDonald, E ;

Saldivar, A ;

Wideburg, N ;

Chen, XQ ;

Niu, P ;

Park, C ;

Jayanti, V ;

Grabowski, B ;

Granneman, GR ;

Sun, E ;

Japour, AJ ;

Leonard, JM ;

Plattner, JJ ;

Norbeck, DW .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (12) :3218-3224

← 1 →